Company · founded 2009
Aquilus Pharmaceuticals (United States)
Winchester, United States · aquiluspharma.com
- Citations, last 5 years
- 5
- Works, last 5 years
- 1
- h-index
- 5
- Scientists listed
- 0
- Grants since 2016
- 3
Grants received
2023–2025 · award
Clinical trial of a matrix metalloproteinase inhibitor for the treatment of ALS
Irving Sucholeiki · Aquilus Pharmaceuticals (United States) · funded by ALS Association
2021–2023 · award
Development of a matrix metalloproteinase inhibitor for the treatment of ALS
Irving Sucholeiki · Aquilus Pharmaceuticals (United States) · funded by ALS Association
2019–2021 · research · R43
Matrix Metalloproteinase-2/-9 Inhibitor For The Treatment Of ALS
Irving Sucholeiki · Aquilus Pharmaceuticals (United States) · funded by National Institutes of Health